PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Health

6-minute daily habit could help Ozempic users preserve muscle, expert says

A 40-week study found that resistance training helped people taking tirzepatide lose 25% less lean tissue while improving strength by 10%.

19sources
20articles
22velocity
+56%since first seen
8d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

Coverage regarding GLP-1 medications focused on related muscle loss claims, nutrient deficiencies, and strategies such as resistance training or daily habits to preserve muscle mass. Following the initial reporting, the story quieted without a definitive conclusion in the coverage.

Epilogue added 2d ago, after coverage quieted.

The brief

A randomized controlled trial published in Nature Medicine found that resistance training preserves lean and muscle mass and increases strength in people taking the GLP-1 weight-loss drug tirzepatide, sold as Mounjaro. Medical Xpress reported on the Tirzepatide and Resistance Exercise (T-REx) study, led by Winthrop Professor Danny Green of The University of Western Australia's School of Human Sciences and HealthSpan Institute. Green said resistance exercise should be part of the prescription when people use a weight-loss drug such as tirzepatide.

The study followed 120 men and postmenopausal women aged 50 to 70 who were obese, or overweight with a weight-related health issue, but without type 2 diabetes. All were prescribed tirzepatide for weight management. Half took part in three sessions of resistance training each week, and all participants received general advice on hydration, protein, and fiber intake.

Both groups lost a similar amount of weight. The trained group lost an average of 22.28 kg (49.1 pounds), while the untrained group lost 22.61 kg (49.8 pounds) after 40 weeks. Fat loss was also comparable, with the trained group losing 17.98 kg (39.6 pounds) and the untrained group losing 17.19 kg (37.9 pounds).

The key difference was in lean tissue and strength. Participants who did resistance training lost 25% less lean tissue, including muscle, than those who did not. Upper- and lower-body strength improved by 10% in the resistance training group, while it declined by 10% in the group that did not train.

Green said loss of lean mass, including muscle, is an inevitable part of weight loss by any method, whether through diet and exercise alone or medical or surgical interventions. He noted that GLP-1 medicines reduce body weight by an average of 20% to 25%, and more in many people, making it crucial to understand how to achieve optimal body composition and health in the weight-reduced state. He said the goal for those taking weight-loss drugs should be to improve health and function, not just a lower number on the scale.

The headlines frame the finding as a six-minute daily habit that could help Ozempic users preserve muscle, citing an expert. The source text itself describes three weekly resistance training sessions rather than a six-minute daily routine, and it focuses on tirzepatide rather than semaglutide, the active ingredient in Ozempic and Wegovy. Medical Xpress said the study is the first to show the effects of combining a GLP-1 medicine and resistance training on body composition, muscle mass, strength, and a range of cardiovascular health measures.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4d ago.

Quick answers

What did the T-REx study find about resistance training and GLP-1 weight-loss drugs?

Participants taking tirzepatide who did resistance training lost 25% less lean tissue, including muscle, than those who did not, and their upper- and lower-body strength improved by 10% while it declined by 10% in the untrained group.

How much weight did participants lose in the study?

The trained group lost an average of 22.28 kg (49.1 pounds) and the untrained group lost 22.61 kg (49.8 pounds) after 40 weeks.

Who led the study and where was it published?

Winthrop Professor Danny Green of The University of Western Australia led the study, which was published in Nature Medicine.

Coverage (20)

Topics

Related trends

▲ Peaking Business

The GLP-1 boom has a dark side

FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.

5 sources 5 articles v 14 1d ago
\n \n \n \n \n \n \n